Ascletis Pharma Inc. (01672)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| KPMG | 29-Jun-23 | |||
| KPMG (Hong Kong) | 29-Jun-23 | |||
| Ernst & Young | 29-Jun-23 | Could not reach a consensus on the audit fee. | ||
| Ernst & Young (Hong Kong) | 20-Jul-18 | 29-Jun-23 | Historical transition (details not available in archive) |